Oncoprotein immunoreactivity in human endocrine tumours

Abnormally expressed oncogenes are implicated in neoplastic transformation. We have investigated a series of endocrine tumours using immunocytochemistry as a first screening tool to detect oncogene expression. Paraffin sections of 44 pulmonary small cell carcinomas, 15 pulmonary atypical carcinoids, 12 bronchial carcinoids, 28 medullary thyroid carcinomas, 27 phaeochromocytomas, and 17 insulinomas were immunostained with antibodies to c‐erbB‐2, c‐myc, L‐myc, and N‐myc. Diffuse immunoreactivity was detectable for c‐erbB‐2 in 8 out of 44 (18 per cent) pulmonary small cell carcinomas, 3 out of 15 (20 per cent) pulmonary atypical carcinoids, and 6 out of 27 (22 per cent) phaeochromocytomas; for c‐myc in 18 out of 44 (41 per cent) pulmonary small cell carcinomas and 5 out of 15 (33 per cent) pulmonary atypical carcinoids; for N‐myc in 6 out of 28 (21 per cent) medullary thyroid carcinomas; and for L‐myc in 4 out of 27 (15 per cent) phaeochromocytomas. There was considerable intratumoral and intertumoral heterogeneity and, in each tumour group, no relationship was found between tumour pattern, mitotic index, and oncoprotein immunoreactivity. These results suggest that oncogene products are present in a proportion of endocrine tumours, and that specific oncoproteins seem to be related to tumour type but not to other histopathological findings. Thus, oncoprotein detection may be a useful tool for identifying subsets of endocrine tumours that are not otherwise recognizable morphologically.

[1]  W. Gullick,et al.  NCL‐CB11, a new monoclonal antibody recognizing the internal domain of the c‐erbB‐2 oncogene protein effective for use on formalin‐fixed, paraffin‐embedded tissue , 1990, The Journal of pathology.

[2]  T. Yanase,et al.  Expression of c-fos and c-myc proto-oncogenes in human adrenal pheochromocytomas. , 1990, The Journal of clinical endocrinology and metabolism.

[3]  M. Kraus,et al.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Sikora,et al.  Oncogene expression in cholangiocarcinoma and in normal hepatic development. , 1989, Human pathology.

[5]  M. Vijver,et al.  The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues , 1989, Histopathology.

[6]  W. Gullick,et al.  c‐erbB‐2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study , 1989, The Journal of pathology.

[7]  P. Quirke,et al.  c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma. , 1989, British Journal of Cancer.

[8]  J. Roth,et al.  Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. , 1989, Cancer research.

[9]  J. Pipas,et al.  Expression of the myc gene family in different stages of human colorectal cancer. , 1989, Oncogene.

[10]  K. Isono,et al.  Expression of c‐myc oncogene in colorectal polyps as a biological marker for monitoring malignant potential , 1989, Cancer.

[11]  J. Osinga,et al.  Amplification and expression of different myc‐family genes in a tumor specimen and 3 cell lines derived from one small‐cell lung cancer patient during longitudinal follow‐up , 1989, International journal of cancer.

[12]  K. Alitalo,et al.  Oncogene expression in small‐cell lung cancer cell lines and a testicular germ‐cell tumor: Activation of the N‐myc gene and decreased RB mRNA , 1989, International journal of cancer.

[13]  Stewart Cc Flow cytometric analysis of oncogene expression in human neoplasias. , 1989 .

[14]  J. Kemshead,et al.  N-myc gene expression and oncoprotein characterisation in medulloblastoma. , 1989, British Journal of Cancer.

[15]  R. Ueda,et al.  Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. , 1989, Cancer research.

[16]  G. Klein,et al.  Oncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity , 1989, Japanese journal of cancer research : Gann.

[17]  B Angus,et al.  Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. , 1989, Cancer research.

[18]  F. Bosman,et al.  Expression of c-myc proto-oncogene in normal human intestinal epithelium. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  M. Greene,et al.  The neu (c-erbB-2) oncogene. , 1989, Seminars in oncology.

[20]  G. Merlo,et al.  In situ detection of c-myc mRNA in adenocarcinomas, adenomas, and mucosa of human colon. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  M. Mathieu,et al.  Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significance , 1989, International journal of cancer.

[22]  J. Imanishi,et al.  Differential expression of n‐myc and c‐src proto‐oncogenes during neuronal and schwannian differentiation of human neuroblastoma cells , 1989, International journal of cancer.

[23]  T. Stephenson,et al.  C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy. , 1989, Journal of clinical pathology.

[24]  A. Nakagawara,et al.  N-myc gene product expression in neuroblastoma. , 1989, Journal of clinical pathology.

[25]  S. Hirohashi,et al.  Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[26]  F. Wyllie,et al.  N-myc expression in neoplasia of human thyroid C-cells. , 1988, Cancer Research.

[27]  J. Minna,et al.  A study of myc-related gene expression in small cell lung cancer by in situ hybridization. , 1988, The American journal of pathology.

[28]  J. Yokota,et al.  Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. , 1988, Oncogene.

[29]  E. Jaffe,et al.  c-myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution. , 1988, The American journal of pathology.

[30]  B. Groner,et al.  Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. , 1988, Cancer research.

[31]  D. Slamon,et al.  Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis. , 1988, Cancer research.

[32]  H. Höfler,et al.  Oncogene expression in a medullary thyroid carcinoma , 1987, Virchows Archiv. B, Cell pathology including molecular pathology.

[33]  A. Thor,et al.  Immunohistochemical evaluation of ras oncogene expression in pulmonary and pleural neoplasms , 1987, Virchows Archiv. B, Cell pathology including molecular pathology.

[34]  J. Yokota,et al.  Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. , 1987, Cancer research.

[35]  V. Chan,et al.  Cellular oncogenes in neoplasia. , 1987, Journal of clinical pathology.

[36]  M. Berger,et al.  Expression of the c‐erbB‐2 protein in normal and transformed cells , 1987, International journal of cancer.

[37]  M. Berger,et al.  Epidermal growth factor receptors in lung tumours , 1987, The Journal of pathology.

[38]  J. Bergh,et al.  Increased expression of N-myc in human small cell lung cancer biopsies predicts lack of response to chemotherapy and poor prognosis. , 1987, American journal of clinical pathology.

[39]  T. Sekiya,et al.  Human cancer and cellular oncogenes. , 1987, The Biochemical journal.

[40]  G. Riou,et al.  C-myc PROTO-ONCOGENE EXPRESSION AND PROGNOSIS IN EARLY CARCINOMA OF THE UTERINE CERVIX , 1987, The Lancet.

[41]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[42]  P. Hand,et al.  ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[43]  J. Yokota,et al.  AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO , 1986, The Lancet.

[44]  L. Kaczmarek Protooncogene expression during the cell cycle. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[45]  J. Battey,et al.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer , 1985, Nature.

[46]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[47]  W. Gullick,et al.  c‐erbB‐2 oncoprotein expression in primary human tumors , 1990, Cancer.

[48]  D. Weiner,et al.  Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract. , 1989, Oncogene.

[49]  H. E. Gray,et al.  Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.